Do the Form 3 entries show any Eltek share purchases or sales by Dovev Gad?

The entries describe existing employee stock option holdings rather than open-market share purchases or sales. The transactions are coded as holdings, with no buy or sell activity indicated in the summarized transaction data for this filing.

Eltek director discloses stock option holdings

Eltek Ltd director Dovev Gad has reported existing equity awards through a Form 3 filing.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Eltek Ltd director Dovev Gad has reported existing equity awards through a Form 3 filing. He holds employee stock options over 20,000 ordinary shares with an exercise price of $5.89 per share, expiring on September 6, 2031.

He also holds options over 10,000 ordinary shares with an exercise price of $8.67 per share, expiring on October 6, 2033. Footnotes state each grant vests over four years, with 25% vesting after one year from the grant date and 6.25% at the end of each following quarter.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Dovev Gad

Role Director

Type	Security	Shares	Price	Value
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--

Holdings After Transaction: Employee Stock Option — 30,000 contracts (Direct)

Footnotes (2)

F1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021
F2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Eltek (ELTK) director Dovev Gad report in this Form 3?

The Form 3 reports that director Dovev Gad holds employee stock options in Eltek. These options cover 30,000 underlying ordinary shares across two grants, establishing his initial derivative ownership as a company insider.

How many Eltek (ELTK) shares are covered by Dovev Gad’s stock options?

Dovev Gad’s options cover 20,000 underlying ordinary shares at one strike price and 10,000 underlying ordinary shares at another. These derivative holdings represent his potential equity exposure upon exercise, subject to vesting schedules and expiration dates.

What are the exercise prices and expirations of Dovev Gad’s Eltek options?

One Eltek option grant has an exercise price of $5.89 per share and expires on September 6, 2031. The second has an exercise price of $8.67 per share and expires on October 6, 2033, both reflecting long-dated incentive awards.

How do Dovev Gad’s Eltek stock options vest over time?

Each option grant vests over four years. Twenty-five percent becomes exercisable on the first anniversary of the respective grant date, then an additional 6.25% becomes exercisable at the end of each subsequent quarter until fully vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 07:33 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dovev Gad

(Last)

(First)

(Middle)

MOTA GUR 12/36

(Street)

GIVAT SHMUEL

5442212

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ELTEK LTD [ ELTK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option	⁽¹⁾	09/06/2031	Ordinary share	20,000	$5.89	D
Employee Stock Option	⁽²⁾	10/06/2033	Ordinary share	10,000	$8.67	D

Explanation of Responses:

1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021

2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023

	/s/ Gad Dovev	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR